Crescent Capital BDC (NASDAQ:CCAP) Posts Quarterly Earnings Results, Beats Estimates By $0.01 EPS

Crescent Capital BDC (NASDAQ:CCAPGet Free Report) posted its quarterly earnings results on Monday. The company reported $0.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.58 by $0.01, Yahoo Finance reports. The business had revenue of $48.95 million for the quarter, compared to analysts’ expectations of $48.05 million. Crescent Capital BDC had a return on equity of 11.99% and a net margin of 53.32%. During the same quarter last year, the business earned $0.56 earnings per share.

Crescent Capital BDC Trading Up 0.3 %

Crescent Capital BDC stock traded up $0.05 during midday trading on Wednesday, hitting $17.82. 201,209 shares of the stock were exchanged, compared to its average volume of 142,485. The stock has a market capitalization of $660.44 million, a PE ratio of 6.32 and a beta of 0.81. The company has a fifty day simple moving average of $18.75 and a two-hundred day simple moving average of $17.72. The company has a quick ratio of 1.36, a current ratio of 1.36 and a debt-to-equity ratio of 1.11. Crescent Capital BDC has a 52 week low of $15.03 and a 52 week high of $19.63.

Crescent Capital BDC Cuts Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, September 16th. Stockholders of record on Saturday, August 31st will be paid a $0.09 dividend. The ex-dividend date is Friday, August 30th. This represents a $0.36 dividend on an annualized basis and a dividend yield of 2.02%. Crescent Capital BDC’s dividend payout ratio (DPR) is presently 59.79%.

Wall Street Analyst Weigh In

CCAP has been the topic of several recent research reports. Keefe, Bruyette & Woods raised their target price on shares of Crescent Capital BDC from $18.50 to $19.00 and gave the company an “outperform” rating in a research note on Thursday, May 23rd. Wells Fargo & Company cut their price objective on shares of Crescent Capital BDC from $19.00 to $18.00 and set an “equal weight” rating on the stock in a report on Wednesday. Finally, Raymond James lifted their target price on shares of Crescent Capital BDC from $18.00 to $19.00 and gave the stock an “outperform” rating in a report on Friday, May 10th.

Check Out Our Latest Research Report on Crescent Capital BDC

Crescent Capital BDC Company Profile

(Get Free Report)

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.

See Also

Earnings History for Crescent Capital BDC (NASDAQ:CCAP)

Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.